JPMORGAN CHASE & CO

Position in CLYM — Climb Bio, Inc.

CIK 19617 NEW YORK, NY

Position in CLYM

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$191,035

+$190,720 QoQ

Shares Held

14,650

+31747.8% QoQ

Ownership

0.026%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#79

of 108 holders

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. CLYM ranks #237 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,517,600	$3,237,487,438
2	REGN	Regeneron Pharmaceuticals, Inc.	3,774,199	$2,353,364,036
3	INSM	INSMED Inc	10,428,170	$1,111,851,478
4	ALNY	Alnylam Pharmaceuticals, Inc.	2,675,517	$805,410,876
5	RVMD	Revolution Medicines, Inc.	3,298,066	$617,661,794
6	RYTM	Rhythm Pharmaceuticals, Inc.	2,652,746	$294,534,385
7	JAZZ	Jazz Pharmaceuticals plc	1,160,786	$279,714,596
8	QURE	uniQure N.V.	4,867,755	$224,208,791

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$191,035	14,650	+31747.8%	Shares	Defined	2026-08-12
2026-03-31	$315	46	0.0%	Shares	Defined	2026-05-13
2025-12-31	$184	46	-99.8%	Shares	Defined	2026-02-11
2025-09-30	$44,243	22,012	-89.5%	Shares	Defined	2025-11-07
2025-06-30	$260,550	210,122	-31.4%	Shares	Defined	2025-08-12
2025-03-31	$373,836	306,424	+5.0%	Shares	Defined	2025-05-12
2024-12-31	$525,232	291,796	+2183.9%	Shares	Defined	2025-02-12
2024-09-30	$65,029	12,776	+311.6%	Shares	Defined	2024-12-26
2024-06-30	$22,069	3,104	+310300.0%	Shares	Defined	2024-12-26
2023-12-31	$2	1	-100.0%	Shares	Defined	2024-12-26
2022-03-31	$23,735	2,829	-98.6%	Shares	Defined	2022-05-11
2021-12-31	$2,175,972	208,028	+2.3%	Shares	Defined	2022-02-11
2021-09-30	$3,657,815	203,438	—	Shares	Defined	2021-11-12
No filing history on record for this holder in this stock.